|
Objective: This study using rigorous randomized controlled trials (RCT Randomized Controlled Trial), functional dyspepsia common clinical disease to study the carrier of acupuncture stomach specific point, the non-acupoint and oral Ito will benefit three kinds differences in efficacy of the treatment of this disease. Methods: In this study, multi-center, randomized, controlled clinical trial design included a total of 354 patients, which depigmentation, excluding cases of 14 cases. All patients were randomly divided into three groups, group A treatment group (stomach control group 1 (non-acupoint group by the specific acupoint group) and group B), C group control groups (itopride group), A B groups will be using conventional acupuncture and electro-acupuncture treatment C group was treated with itopride tablets, 50mg tid, a total of 4 weeks of treatment, treatment breaks 2 days, 1 month and 3 months after the end of treatment follow-up. Were enrolled in two weeks, four weeks, follow-up for efficacy evaluation. To the the NDI scale quality of life ratings Chinese version of dyspepsia symptom scores, overall efficacy in patients evaluated the efficacy endpoint, objective evaluation of the three groups of the clinical efficacy of the treatment of FD. Three groups: (1) baseline in good condition, grouping balanced, strong comparable (P> 0.05). (2) A group and B group comparison, the rating of the group into two weeks, the end of treatment, follow-up time point NDI scale quality of life in all areas, as well as efficacy evaluation point in time in addition to epigastric burning sensation, postprandial fullness , early satiety symptoms, abdominal pain score on the two groups have a significant difference (P lt; 0.05) (3) A group and C group compared to the end of treatment, follow-up NDI scale in four areas rating, as well as postprandial fullness, early satiety, abdominal pain score were significant differences (P <0.05 ( 4) B and C groups, the NDI scale interference field and the field of sleep score at the the Evaluation point in time, the field of food and awareness in the two weeks of treatment and end of treatment were different (P <0.05). postprandial fullness, early satiety, symptoms of upper abdominal pain score between the two groups have a significant difference (P <0.05) (5) three groups in the overall evaluation of the end of treatment efficacy in patients with a significant difference (P <0.05). Conclusion: (1) the efficacy of acupuncture group A on the quality of life in patients with each of the four areas of valuation point are better than group C; A and group C treatment efficacy of two weeks, but the end of treatment and follow-up of efficacy evaluation A group gt; the C group gt; B group. (2) acupuncture group A in improving the FD patients abdominal pain, postprandial fullness, early satiety symptoms, the efficacy evaluation point in time were superior to the other two groups ; improving the epigastric burning sensation between the three groups, group efficacy de facto epigastric burning sensation integrator without a difference. (3) overall efficacy evaluation of patients in group A is better than B, C group.
|